Chronic myeloid leukemia (CML) is a hematopoietic stem cell (HSC) disease characterized by the translocation t(9;22)(q34;q11), resulting in the fusion of the BCR and ABL1 genes. The gene discussed is BCR; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.